Equity-Insider.com News Commentary -- Big money is moving back into biotech. Institutional investors have been writing some of the largest checks in years, with major financing rounds already closing ...
ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced four strategic additions to its executive leadership team: Jeff ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research ...
IPN01203 data to be presented at coveted New Drugs on the Horizon program session, demonstrating early potential of this novel T cell activator to transform care in solid tumors ITGA2 revealed as ...
Revolution Medicines, Inc. (Nasdaq:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that nine oral and poster ...
Good news: cancer death rates in the UK have fallen to their lowest level on record. According to the latest statistics from Cancer Research UK, between 2022 and 2024, around 247 people per 100,000 ...
The New Times on MSN
Health: A look at 10 research breakthroughs made in last two years
Over the last two years, research has improved the understanding and treatment of disease. Using tools such as gene editing, ...
This past week, LCGC International highlighted recent milestones and research advancements in the field of chromatography and analytical science. Key announcements from Pittcon 20 ...
Until now, the following has been true for metastatic pancreatic cancer: Once the tumor has spread, local treatment such as surgery is usually no longer an option.
In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit desired safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results